Endonovo Therapeutics is partnering with medical device reimbursement specialist NAMSA to build outpatient and inpatient reimbursement strategies for Endonovo’s pulsed electromagnetic field device SofPulse.
Medical devicemaker enlists partner to bolster outpatient reimbursement
